Lidocaine HCl Sterile Buffered Solution for Injection (PF) 1%, 10mL per syringe, Single Use Syrin...

FDA Recall #D-0395-2022 — Class II — December 6, 2021

Recall #D-0395-2022 Date: December 6, 2021 Classification: Class II Status: Terminated

Product Description

Lidocaine HCl Sterile Buffered Solution for Injection (PF) 1%, 10mL per syringe, Single Use Syringe for Infiltration and Nerve Block, Edge Pharma, LLC, 856 Hercules Dr., Colchester, VT 05446, NDC 05446-0850-10

Reason for Recall

Lack of Assurance of Sterility

Recalling Firm

Edge Pharma, LLC — Colchester, VT

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

4465 syringes

Distribution

nationwide

Code Information

08-2021-27@3 12/09/2021 09-2021-24@1 01/06/2022 10-2021-14@2 01/31/2022

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated